Cargando…

Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer

BACKGROUND: Since December 2009 a new VMAT planning system tool is available in Oncentra® MasterPlan v3.3 (Nucletron B.V.). The purpose of this study was to work out standard parameters for the optimization of prostate cancer. METHODS: For ten patients with localized prostate cancer plans for simult...

Descripción completa

Detalles Bibliográficos
Autores principales: Treutwein, Marius, Hipp, Matthias, Koelbl, Oliver, Dobler, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434122/
https://www.ncbi.nlm.nih.gov/pubmed/22784505
http://dx.doi.org/10.1186/1748-717X-7-108
_version_ 1782242397826056192
author Treutwein, Marius
Hipp, Matthias
Koelbl, Oliver
Dobler, Barbara
author_facet Treutwein, Marius
Hipp, Matthias
Koelbl, Oliver
Dobler, Barbara
author_sort Treutwein, Marius
collection PubMed
description BACKGROUND: Since December 2009 a new VMAT planning system tool is available in Oncentra® MasterPlan v3.3 (Nucletron B.V.). The purpose of this study was to work out standard parameters for the optimization of prostate cancer. METHODS: For ten patients with localized prostate cancer plans for simultaneous integrated boost were optimized, varying systematically the number of arcs, collimator angle, the maximum delivery time, and the gantry spacing. Homogeneity in clinical target volume, minimum dose in planning target volume, median dose in the organs at risk, maximum dose in the posterior part of the rectum, and number of monitor units were evaluated using student’s test for statistical analysis. Measurements were performed with a 2D-array, taking the delivery time, and compared to the calculation by the gamma method. RESULTS: Plans with collimator 45° were superior to plans with collimator 0°. Single arc resulted in higher minimum dose in the planning target volume, but also higher dose values to the organs at risk, requiring less monitor units per fraction dose than dual arc. Single arc needs a higher value (per arc) for the maximum delivery time parameter than dual arc, but as only one arc is needed, the measured delivery time was shorter and stayed below 2.5 min versus 3 to 5 min. Balancing plan quality, dosimetric results and calculation time, a gantry spacing of 4° led to optimal results. CONCLUSION: A set of parameters has been found which can be used as standard for volumetric modulated arc therapy planning of prostate cancer.
format Online
Article
Text
id pubmed-3434122
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34341222012-09-06 Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer Treutwein, Marius Hipp, Matthias Koelbl, Oliver Dobler, Barbara Radiat Oncol Research BACKGROUND: Since December 2009 a new VMAT planning system tool is available in Oncentra® MasterPlan v3.3 (Nucletron B.V.). The purpose of this study was to work out standard parameters for the optimization of prostate cancer. METHODS: For ten patients with localized prostate cancer plans for simultaneous integrated boost were optimized, varying systematically the number of arcs, collimator angle, the maximum delivery time, and the gantry spacing. Homogeneity in clinical target volume, minimum dose in planning target volume, median dose in the organs at risk, maximum dose in the posterior part of the rectum, and number of monitor units were evaluated using student’s test for statistical analysis. Measurements were performed with a 2D-array, taking the delivery time, and compared to the calculation by the gamma method. RESULTS: Plans with collimator 45° were superior to plans with collimator 0°. Single arc resulted in higher minimum dose in the planning target volume, but also higher dose values to the organs at risk, requiring less monitor units per fraction dose than dual arc. Single arc needs a higher value (per arc) for the maximum delivery time parameter than dual arc, but as only one arc is needed, the measured delivery time was shorter and stayed below 2.5 min versus 3 to 5 min. Balancing plan quality, dosimetric results and calculation time, a gantry spacing of 4° led to optimal results. CONCLUSION: A set of parameters has been found which can be used as standard for volumetric modulated arc therapy planning of prostate cancer. BioMed Central 2012-07-11 /pmc/articles/PMC3434122/ /pubmed/22784505 http://dx.doi.org/10.1186/1748-717X-7-108 Text en Copyright ©2012 Treutwein et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Treutwein, Marius
Hipp, Matthias
Koelbl, Oliver
Dobler, Barbara
Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer
title Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer
title_full Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer
title_fullStr Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer
title_full_unstemmed Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer
title_short Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer
title_sort searching standard parameters for volumetric modulated arc therapy (vmat) of prostate cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434122/
https://www.ncbi.nlm.nih.gov/pubmed/22784505
http://dx.doi.org/10.1186/1748-717X-7-108
work_keys_str_mv AT treutweinmarius searchingstandardparametersforvolumetricmodulatedarctherapyvmatofprostatecancer
AT hippmatthias searchingstandardparametersforvolumetricmodulatedarctherapyvmatofprostatecancer
AT koelbloliver searchingstandardparametersforvolumetricmodulatedarctherapyvmatofprostatecancer
AT doblerbarbara searchingstandardparametersforvolumetricmodulatedarctherapyvmatofprostatecancer